Ed Miliband: 'Serious concerns' over proposed Pfizer deal

Following a brief 30 minute with Pfizer chief executive Ian Read after today's hearing Mr Miliband said: "There are serious concerns about this proposed takeover. There are too many unanswered questions about British science and British industry".

View all 18 updates ›

Pfizer deal 'will make almost no difference to the NHS'

Pfizer's proposed takeover of AstraZeneca will make "almost no difference to the NHS", an expert on cancer treatment has told ITV News.

Dr Karol Sikora of the University of Buckingham said the majority of drug development was now undertaken by academics and smaller biotechnology companies, rather than big pharmaceutical firms.

He also argued that the economies of scale enabled by a merger between the two firms could mean more research funding that would ultimately benefit patients.

More on this story